Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction in South Korea

Pil Sang Song1, Kye Taek Ahn2, Mi Joo Kim2

  • 1Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea. pssong73@gmail.com.

Korean Circulation Journal
|February 19, 2026
PubMed

Insights

Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) decreased over a decade, with improved survival for pre-admission CS. However, in-hospital CS survival did not improve, highlighting the need for better prevention and treatment strategies.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI).
  • Understanding temporal trends and predictors of CS is crucial for improving patient outcomes.
  • Previous studies have varied in their focus on CS development and mortality.

Purpose of the Study:

  • To investigate temporal trends in the prevalence of cardiogenic shock complicating AMI.
  • To identify predictors of CS development during hospitalization.
  • To assess predictors of mortality in patients with CS following AMI.

Main Methods:

  • Utilized data from two Korean AMI Registries (KAMIR-NIH and KAMIR-V) spanning 2011-2020.
  • Categorized CS into CS before admission (ba-CS) and CS developing during admission (da-CS).
  • Analyzed temporal trends by dividing the study period into early (2011-2015) and late (2016-2020) phases.

Main Results:

  • Overall CS prevalence decreased from 12.5% to 9.6% (p<0.001), with reductions in both ba-CS and da-CS.
  • Percutaneous coronary intervention use increased significantly over the study period.
  • In-hospital mortality decreased for overall CS (27.3% to 22.9%) and ba-CS (25.1% to 17.0%), but not for da-CS (30.3% to 32.9%).

Conclusions:

  • While overall and pre-admission CS mortality has declined, the lack of improvement in in-hospital CS mortality necessitates enhanced prevention strategies.
  • Early identification of CS development post-admission is critical.
  • Alternative therapeutic strategies are needed for high-risk patients developing CS during the acute phase of AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...